Asian Symposium on ADMET Profiling for Drug Discovery:
Metabolism and Drug Safety
| Date: |
15th – 16th September 2009 |
Venue:
|
Kent Ridge Guild House, National University of Singapore (NUS)
Click here for the maps and here for the directions |
| Host: |
Department of Pharmacy, NUS |
| Organizers: |
Dr. Eric Chan, Dr. Ho Han Kiat |
| Scientific Advisor: |
Prof Dhiren Thakker, University of North Carolina |
This is a one-and-a-half day symposium focusing on the frontiers of pharmacokinetics and toxicology research pertaining to drug development and drug usage. The specific theme "Metabolism and Drug Safety" will be expounded by renowned speakers in the field including Professor Dhiren Thakker (University of North Carolina, Chapel Hill), and Professor Sidney Nelson (University of Washington, Seattle). A half-day graduate student/post-doc mini-symposium will be incorporated for scientific networking amongst burgeoning scientists. This will comprise a series of platform presentations of outstanding abstracts by winners of the Student/Post-doc Travel Awards.
Please click here for the programme highlights
 Dr. Dhiren R. Thakker Ferguson Distinguished Professor Associate Dean, Economic Development and International Partnerships School of Pharmacy, University of North Carolina

Title: Structure Toxicity Relationships in Reactive Metabolite-Mediated Drug Toxicities
Dr. Sidney D. Nelson
NUSS Professor
Dean Emeritus
School of Pharmacy, University of Washington

Title: Risk Assessment of Chemicals from the Perspective of Physiologically based Pharmacokinetic Modelling.
Dr. Peter Chan, PhD, DABT
Managing Director
PCTS Specialty Chemicals Pte Ltd
Adjunct Associate Professor,
Department of Chemistry, NUS

Title: Quinone toxicity- friend or foe?
Dr. Salmaan H Inayat-Hussain, PhD, ERT
Professor of Toxicology
Deputy Dean
Faculty of Allied Health Sciences
Universiti Kebangsaan Malaysia

Title: Metabonomics as a Tool for Predicting Drug Response
Dr. Hector Keun
Lecturer in Biological Chemistry
Imperial College London
.jpg)
Title: Covalent Binding of Reactive Metabolites as a Problem in Industrial Drug Discovery
Dr. Ronald White, Ph.D
Distinguished Research Fellow
Pharmaceutical Candidate Optimization
Bristol-Myers Squibb
|